Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.

Kadota M, Yang HH, Gomez B, Sato M, Clifford RJ, Meerzaman D, Dunn BK, Wakefield LM, Lee MP.

PLoS One. 2010 Feb 15;5(2):e9201. doi: 10.1371/journal.pone.0009201.

2.

Identification of novel gene amplifications in breast cancer and coexistence of gene amplification with an activating mutation of PIK3CA.

Kadota M, Sato M, Duncan B, Ooshima A, Yang HH, Diaz-Meyer N, Gere S, Kageyama S, Fukuoka J, Nagata T, Tsukada K, Dunn BK, Wakefield LM, Lee MP.

Cancer Res. 2009 Sep 15;69(18):7357-65. doi: 10.1158/0008-5472.CAN-09-0064. Epub 2009 Aug 25.

3.

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.

Bessette DC, Tilch E, Seidens T, Quinn MC, Wiegmans AP, Shi W, Cocciardi S, McCart-Reed A, Saunus JM, Simpson PT, Grimmond SM, Lakhani SR, Khanna KK, Waddell N, Al-Ejeh F, Chenevix-Trench G.

PLoS One. 2015 May 13;10(5):e0125232. doi: 10.1371/journal.pone.0125232. eCollection 2015.

4.

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T.

BMC Genomics. 2008 Jul 29;9:353. doi: 10.1186/1471-2164-9-353.

5.

Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.

Maguire SL, Peck B, Wai PT, Campbell J, Barker H, Gulati A, Daley F, Vyse S, Huang P, Lord CJ, Farnie G, Brennan K, Natrajan R.

J Pathol. 2016 Nov;240(3):315-328. doi: 10.1002/path.4778.

6.

[Promoter methylation and mRNA expression of WT1 gene in MCF10 breast cancer model].

Yang JL, Klinkebiel D, Boland MJ, Tang L, Christman JK.

Zhonghua Bing Li Xue Za Zhi. 2007 Apr;36(4):253-8. Chinese.

PMID:
17706117
7.

[Promoter methylation and mRNA expression of APC gene in MCF10 breast cancer model].

Yang JL, Klinkebiel D, Boland MJ, Tang L, Christman JK.

Zhonghua Bing Li Xue Za Zhi. 2006 Jan;35(1):32-6. Chinese.

PMID:
16608647
8.

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.

Riaz M, van Jaarsveld MT, Hollestelle A, Prager-van der Smissen WJ, Heine AA, Boersma AW, Liu J, Helmijr J, Ozturk B, Smid M, Wiemer EA, Foekens JA, Martens JW.

Breast Cancer Res. 2013 Apr 19;15(2):R33. doi: 10.1186/bcr3415.

9.

Differential gene expression of Wnt signaling pathway in benign, premalignant, and malignant human breast epithelial cells.

Wang YZ, Han YS, Ma YS, Jiang JJ, Chen ZX, Wang YC, Che W, Zhang F, Xia Q, Wang XF.

Tumour Biol. 2012 Dec;33(6):2317-27. doi: 10.1007/s13277-012-0494-0. Epub 2012 Sep 1.

PMID:
22941468
10.

High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model.

Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, van Spaendonk R, Wolman SR.

Breast Cancer Res Treat. 2006 Mar;96(2):177-86.

PMID:
16319984
11.

The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.

Aprelikova O, Chen K, El Touny LH, Brignatz-Guittard C, Han J, Qiu T, Yang HH, Lee MP, Zhu M, Green JE.

Clin Epigenetics. 2016 Apr 14;8:38. doi: 10.1186/s13148-016-0205-6. eCollection 2016.

12.

HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.

Teo WW, Merino VF, Cho S, Korangath P, Liang X, Wu RC, Neumann NM, Ewald AJ, Sukumar S.

Oncogene. 2016 Oct 20;35(42):5539-5551. doi: 10.1038/onc.2016.95. Epub 2016 May 9.

13.

High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.

Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP.

Mol Cancer Res. 2009 May;7(5):665-77. doi: 10.1158/1541-7786.MCR-08-0270. Epub 2009 May 12.

14.

Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.

Boonstra JJ, van Marion R, Douben HJ, Lanchbury JS, Timms KM, Abkevich V, Tilanus HW, de Klein A, Dinjens WN.

Genes Chromosomes Cancer. 2012 Mar;51(3):272-82. doi: 10.1002/gcc.20952. Epub 2011 Nov 12.

PMID:
22081516
15.

Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer.

Lee HJ, Liu H, Goodman C, Ji Y, Maehr H, Uskokovic M, Notterman D, Reiss M, Suh N.

Biochem Pharmacol. 2006 Jul 28;72(3):332-43. Epub 2006 May 5.

PMID:
16737686
16.

MYC phosphorylation at novel regulatory regions suppresses transforming activity.

Wasylishen AR, Chan-Seng-Yue M, Bros C, Dingar D, Tu WB, Kalkat M, Chan PK, Mullen PJ, Huang L, Meyer N, Raught B, Boutros PC, Penn LZ.

Cancer Res. 2013 Nov 1;73(21):6504-15. doi: 10.1158/0008-5472.CAN-12-4063. Epub 2013 Sep 12.

17.

ATM suppresses SATB1-induced malignant progression in breast epithelial cells.

Ordinario E, Han HJ, Furuta S, Heiser LM, Jakkula LR, Rodier F, Spellman PT, Campisi J, Gray JW, Bissell MJ, Kohwi Y, Kohwi-Shigematsu T.

PLoS One. 2012;7(12):e51786. doi: 10.1371/journal.pone.0051786. Epub 2012 Dec 10.

18.

High-resolution genomic and expression analyses of copy number alterations in breast tumors.

Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, Lohr S, Wu TD, Cavet G, Zhang Z, Chant J.

Genes Chromosomes Cancer. 2008 Jun;47(6):530-42. doi: 10.1002/gcc.20558.

PMID:
18335499
19.

Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.

Unger K, Wienberg J, Riches A, Hieber L, Walch A, Brown A, O'Brien PC, Briscoe C, Gray L, Rodriguez E, Jackl G, Knijnenburg J, Tallini G, Ferguson-Smith M, Zitzelsberger H.

Endocr Relat Cancer. 2010 Jan 29;17(1):87-98. doi: 10.1677/ERC-09-0065. Print 2010 Mar.

20.

DNA copy number aberrations and disruption of the p16Ink4a/Rb pathway in radiation-induced and spontaneous rat mammary carcinomas.

Iizuka D, Imaoka T, Takabatake T, Nishimura M, Kakinuma S, Nishimura Y, Shimada Y.

Radiat Res. 2010 Aug;174(2):206-15. doi: 10.1667/RR2006.1.

PMID:
20681787

Supplemental Content

Support Center